Nile Therapeutics (NLTX) Posts Narrower than Expected Q4 Loss
Get Alerts NLTX Hot Sheet
Join SI Premium – FREE
Nile Therapeutics, Inc. (NASDAQ: NLTX) reported Q4 loss of $0.02, $0.02 better than the analyst estimate of ($0.04).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share